PTPN14
Basic information
Region (hg38): 1:214348700-214552449
Links
Phenotypes
GenCC
Source:
- lymphedema-posterior choanal atresia syndrome (Supportive), mode of inheritance: AR
- lymphedema-posterior choanal atresia syndrome (Strong), mode of inheritance: AR
- lymphedema-posterior choanal atresia syndrome (Strong), mode of inheritance: AR
- lymphedema-posterior choanal atresia syndrome (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Choanal atresia and lymphedema | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Audiologic/Otolaryngologic; Cardiovascular; Craniofacial | 7158640; 1872518; 20826270 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PTPN14 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 18 | 25 | ||||
missense | 52 | 62 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | 4 | 6 | ||
non coding | 45 | 49 | ||||
Total | 1 | 0 | 56 | 24 | 58 |
Highest pathogenic variant AF is 0.0000592
Variants in PTPN14
This is a list of pathogenic ClinVar variants found in the PTPN14 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-214351602-G-A | Lymphedema-posterior choanal atresia syndrome | Uncertain significance (Nov 22, 2021) | ||
1-214357735-GA-G | Benign (Nov 12, 2018) | |||
1-214357896-C-T | Lymphedema-posterior choanal atresia syndrome | Benign (Nov 07, 2021) | ||
1-214357986-A-G | Lymphedema-posterior choanal atresia syndrome • not specified | Uncertain significance (Sep 15, 2023) | ||
1-214364206-C-T | Benign (Nov 12, 2018) | |||
1-214364284-C-T | Benign (Jun 19, 2021) | |||
1-214364515-G-A | Likely benign (Jun 29, 2018) | |||
1-214364544-C-T | not specified | Uncertain significance (Jul 06, 2021) | ||
1-214364603-G-A | Benign (Dec 31, 2019) | |||
1-214364609-C-T | not specified | Uncertain significance (Nov 18, 2023) | ||
1-214364635-G-A | Benign (Dec 31, 2019) | |||
1-214364636-T-C | not specified | Uncertain significance (Dec 14, 2021) | ||
1-214364943-A-T | Benign (Nov 12, 2018) | |||
1-214369325-T-C | Benign (Nov 12, 2018) | |||
1-214369476-T-C | Lymphedema-posterior choanal atresia syndrome | Benign (Nov 07, 2021) | ||
1-214369548-G-A | Benign (Dec 31, 2019) | |||
1-214369590-C-T | Likely benign (Jun 23, 2018) | |||
1-214369591-G-C | Likely benign (Dec 01, 2023) | |||
1-214369674-T-G | not specified | Uncertain significance (Jan 23, 2024) | ||
1-214369682-G-A | Pathogenic (Jul 05, 2022) | |||
1-214369755-A-G | Benign (Nov 12, 2018) | |||
1-214372417-T-G | Benign (Jun 19, 2021) | |||
1-214373141-G-A | Benign (Nov 12, 2018) | |||
1-214376158-C-T | Benign (Jun 20, 2021) | |||
1-214376267-T-C | not specified | Uncertain significance (Aug 02, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PTPN14 | protein_coding | protein_coding | ENST00000366956 | 18 | 203754 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.221 | 0.779 | 125725 | 0 | 23 | 125748 | 0.0000915 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.68 | 591 | 718 | 0.824 | 0.0000440 | 7814 |
Missense in Polyphen | 202 | 298 | 0.67785 | 3210 | ||
Synonymous | -0.395 | 299 | 290 | 1.03 | 0.0000197 | 2298 |
Loss of Function | 5.50 | 14 | 59.9 | 0.234 | 0.00000367 | 623 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000218 | 0.000213 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000550 | 0.0000544 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.0000884 | 0.0000879 |
Middle Eastern | 0.0000550 | 0.0000544 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000326 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Protein tyrosine phosphatase which may play a role in the regulation of lymphangiogenesis, cell-cell adhesion, cell- matrix adhesion, cell migration, cell growth and also regulates TGF-beta gene expression, thereby modulating epithelial- mesenchymal transition. Mediates beta-catenin dephosphorylation at adhesion junctions. Acts as a negative regulator of the oncogenic property of YAP, a downstream target of the hippo pathway, in a cell density-dependent manner. May function as a tumor suppressor. {ECO:0000269|PubMed:10934049, ECO:0000269|PubMed:12808048, ECO:0000269|PubMed:17893246, ECO:0000269|PubMed:20826270, ECO:0000269|PubMed:22233626, ECO:0000269|PubMed:22525271, ECO:0000269|PubMed:22948661}.;
- Disease
- DISEASE: Choanal atresia and lymphedema (CATLPH) [MIM:613611]: A disease characterized by posterior choanal atresia and lymphedema. Additional features are a high-arched palate, hypoplastic nipples, and mild pectus excavatum. {ECO:0000269|PubMed:20826270}. Note=The disease is caused by mutations affecting the gene represented in this entry. A homozygous deletion in PTPN14 predicted to result in frameshift and premature truncation, has been shown to be the cause of choanal atresia and lymphedema in one family.; DISEASE: Note=Influence clinical severity of hereditary haemorragic telagiectasia (HHT). {ECO:0000269|PubMed:22233626}.;
Recessive Scores
- pRec
- 0.283
Intolerance Scores
- loftool
- 0.166
- rvis_EVS
- -0.3
- rvis_percentile_EVS
- 32.28
Haploinsufficiency Scores
- pHI
- 0.251
- hipred
- Y
- hipred_score
- 0.563
- ghis
- 0.491
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.902
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ptpn14
- Phenotype
- growth/size/body region phenotype; homeostasis/metabolism phenotype; vision/eye phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype;
Gene ontology
- Biological process
- lymphangiogenesis;protein dephosphorylation;negative regulation of cell population proliferation;peptidyl-tyrosine dephosphorylation;regulation of protein export from nucleus;cellular response to cytokine stimulus;regulation of nucleic acid-templated transcription
- Cellular component
- nucleus;nucleoplasm;cytoplasm;cytoskeleton
- Molecular function
- transcription coregulator activity;protein tyrosine phosphatase activity;protein binding;receptor tyrosine kinase binding